Illumos Showcases Next-Generation Pathology at Asia Summit on Global Health 2024

Illumos is delighted to have participated in the prestigious Asia Summit on Global Health 2024. As a specialist in 3D digital pathology, we had the privilege of showcasing the prototype design and patented technology to a distinguished audience of business leaders, industry players, aspiring entrepreneurs and medical professionals.

The event provided a valuable platform for us to share our vision and engage in fruitful discussions about transforming the future of pathology. Our founder and CEO, Prof. Lai Hei Ming was honoured to present the cutting-edge solutions and explore collaborative opportunities to make a lasting impact on the global healthcare landscape.

Moving forward, Illumos remains committed to advancing its technology and delivering transformative solutions that redefine the standards of pathology and patient care worldwide. The company is excited to build upon the momentum gained from the Summit and continue its mission of shaping the future of digital health.